NATIONAL BANK OF CANADA /FI/
BankPosition in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 926171
MONTREAL, A8
Position in ALNY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$15,794,140
-$5,251,507 QoQ
Shares Held
52,467
-17.5% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#149
of 784 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $632,188,402 across 150 Biotechnology names. ALNY ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,096,025 | $205,263,562 | |
| 2 | MRNA |
Moderna, Inc.
|
1,424,802 | $99,778,883 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
2,773,874 | $98,167,400 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
172,898 | $85,883,622 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
125,812 | $78,448,813 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
52,467 | $15,794,140 | |
| 7 | GPCR |
Structure Therapeutics Inc.
|
215,800 | $11,581,986 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
1,233,014 | $9,679,159 |
All Filings in ALNY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,794,140 | 52,467 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $21,045,647 | 63,607 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,417,081 | 66,433 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $436,392 | 957 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $294,458 | 903 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $179,022 | 663 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $157,186 | 668 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $168,592 | 613 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $152,118 | 626 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $16,201,873 | 108,410 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $98,193 | 513 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $85,892 | 485 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $620,343 | 3,266 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $625,598 | 3,123 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $1,005,734 | 4,232 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $1,317,652 | 6,583 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $1,779,369 | 12,200 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $1,990,341 | 12,189 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $815,170 | 4,807 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||